【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
03.2.1 Product Profiles
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07.Market Segmentation by Therapeutic Class
08.Late Stage Pipeline Molecules
09.Geographical Segmentation
09.1 Congestive Heart Failure Drugs Market in Americas
09.1.1 Market Size and Forecast
09.2 Congestive Heart Failure Drugs Market in Europe
09.2.1 Market Size and Forecast
09.3 Congestive Heart Failure Drugs Market in Asia
09.3.1 Market Size and Forecast
09.4 Congestive Heart Failure Drugs Market in ROW
09.4.1 Market Size and Forecast
10.Buying Criteria
11.Market Growth Drivers
12.Drivers and their Impact
13.Market Challenges
14.Impact of Drivers and Challenges
15.Market Trends
16.Trends and their Impact
17.Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors
18.Key Vendor Analysis
18.1 AstraZeneca plc
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue 2013
18.1.4 Business Segmentation by Revenue 2011-2013
18.1.5 Sales by Geography
18.1.6 Business Strategy
18.1.7 Key Developments
18.1.8 SWOT Analysis
18.2 Bristol-Myers Squibb Co.
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Key Product Offerings
18.2.4 Revenue by Geography
18.2.5 Business Strategy
18.2.6 Key Information
18.2.7 SWOT Analysis
18.3 GlaxoSmithKline
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation
18.3.4 Business Segmentation by Revenue 2012 and 2013
18.3.5 Sales by Geography
18.3.6 Pipeline Products
18.3.7 Business Strategy
18.3.8 Key Information
18.3.9 SWOT Analysis
18.4 Merck & Co. Inc.
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2013
18.4.4 Business Segmentation by Revenue 2012 and 2013
18.4.5 Sales by Geography
18.4.6 Business Strategy
18.4.7 Key Developments
18.4.8 SWOT Analysis
18.5 Mylan
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Business Segmentation by Revenue 2013
18.5.4 Business Segmentation by Revenue 2011-2013
18.5.5 Geographical Segmentation by Revenue 2013
18.5.6 Business Strategy
18.5.7 Recent Developments
18.5.8 SWOT Analysis
18.6 Novartis AG
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Business Segmentation
18.6.4 Revenue by Business Segmentation
18.6.5 Revenue Comparison 2012 and 2013
18.6.6 Sales by Geography
18.6.7 Business Strategy
18.6.8 Key Developments
18.6.9 SWOT Analysis
18.7 Pfizer
18.7.1 Key Facts
18.7.2 Business Overview
18.7.3 Business Segmentation by Revenue 2013
18.7.4 Business Segmentation by Revenue 2012 and 2013
18.7.5 Geographical Segmentation by Revenue
18.7.6 Business Strategy
18.7.7 Key Developments
18.7.8 SWOT Analysis
18.8 Sanofi SA
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Business Segmentation
18.8.4 Revenue by Business Segmentation
18.8.5 Revenue Comparison 2012 and 2013
18.8.6 Sales by Geography
18.8.7 Business Strategy
18.8.8 Key Developments
18.8.9 SWOT Analysis
18.9 Valeant Pharmaceuticals International
18.9.1 Key Facts
18.9.2 Business Overview
18.9.3 Business Segmentation by Revenue 2013
18.9.4 Business Segmentation by Revenue 2012 and 2013
18.9.5 Sales by Geography
18.9.6 Business Strategy
18.9.7 Key Developments
18.9.8 SWOT Analysis
19.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Congestive Heart Failure Drugs Market 2014-2019 (US$ billion)
Exhibit 3: Global Congestive Heart Failure Drugs Market Segmentation by Therapeutic Class
Exhibit 4: Congestive Heart Failure: Clinical Developmental Pipeline
Exhibit 5: Global Congestive Heart Failure Drugs Market by Geographical Segmentation 2014
Exhibit 6: Congestive Heart Failure Drugs market in Americas 2014-2019 (US$ billion)
Exhibit 7: Congestive Heart Failure Drugs market in Europe 2014-2019 (US$ billion)
Exhibit 8: Congestive Heart Failure Drugs market in Asia 2014-2019 (US$ billion)
Exhibit 9: Congestive Heart Failure Drugs Market in ROW 2014-2019 (US$ billion)
Exhibit 10: Global Congestive Heart Failure Drugs Market by Geographical Segmentation 2014-2019 (in Percent)
Exhibit 11: Global Congestive Heart Failure Drugs Market by Geographical Segmentation 2014-2019 (in Revenue)
Exhibit 12: Estimated Prevalence of Congestive Heart Failure in Different Age-group (years) in the US
Exhibit 13: Age-specific Male Incidence Rates (per 1000 man years) in Congestive Heart Failure
Exhibit 14: Age-specific Female Incidence Rates (per 1000 woman-years) in Congestive Heart Failure
Exhibit 15: AstraZeneca Year on Year Sales Comparison 2010-2013 (US$ billion)
Exhibit 16: GSK Year on Year Sales Comparison 2010-2013 (US$ billion)
Exhibit 17: GSK’s Total Global Sales of Medicines by Therapeutic Classes 2013 (percentage)
Exhibit 18: GSK Coreg Year on Year Sales Comparison 2010-2013 (US$ billion)
Exhibit 19: Merck & Co. Year on Year Sales Comparison 2010-2013 (US$ billion)
Exhibit 20: Mylan Year on Year Sales Comparison 2010-2013 (US$ billion)
Exhibit 21: Novartis Diovan Year on Year Sales Comparison 2010-2013 (US$ billion)
Exhibit 22: Novartis Year on Year Sales Comparison 2010-2013 (US$ billion)
Exhibit 23: Pfizer Year on Year Sales Comparison 2010-2013 (US$ billion)
Exhibit 24: Sanofi Year on Year Sales Comparison 2010-2013 (US$ billion)
Exhibit 25: Valeant Pharmaceuticals Year on Year Sales Comparison 2010-2013 (US$ billion)
Exhibit 26: Valeant Pharmaceuticals Revenue Breakdown by Product Segments
Exhibit 27: AstraZeneca plc: Business Segmentation by Revenue 2013
Exhibit 28: AstraZeneca plc: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 29: AstraZeneca plc: Sales by Geography 2013
Exhibit 30: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 31: Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013
Exhibit 32: GlaxoSmithKline: Business Segmentation 2013
Exhibit 33: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 34: GlaxoSmithKline: Sales by Geography 2013
Exhibit 35: GlaxoSmithKline: Pipeline Products 2013
Exhibit 36: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 37: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 38: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 39: Global Congestive Heart Failure Drugs Market: Business Segmentation by Revenue 2013
Exhibit 40: Global Congestive Heart Failure Drugs Market: Business Segmentation by Revenue 2011-2013 (US$ billion)
Exhibit 41: Global Congestive Heart Failure Drugs Market: Geographical Segmentation by Revenue 2013
Exhibit 42: Novartis AG: Business Segmentation
Exhibit 43: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 44: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 45: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 46: Pfizer: Business Segmentation by Revenue 2013
Exhibit 47: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 48: Pfizer: Geographical Segmentation by Revenue 2013
Exhibit 49: Sanofi SA: Business Segmentation
Exhibit 50: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 51: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 52: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
Exhibit 53: Valeant Pharmaceuticals International: Business Segmentation by Revenue 2013
Exhibit 54: Valeant Pharmaceuticals International: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 55: Valeant Pharmaceuticals International: Sales by Geography 2013
【レポート販売概要】
■ タイトル：鬱血性心不全治療薬の世界市場2015-2019■ 英文：Global Congestive Heart Failure Drugs Market 2015-2019
■ 発行日：2015年1月28日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5062
■ 調査対象地域：グローバル
- 世界の鉄道産業におけるエネルギー管理システム市場2016-2020About Energy Management Market in Railways An energy management system (EMS) consists of hardware, software, and services that provide energy information to users such as infrastructure managers, financial managers, facility managers, and power utilities. It is also a systematic process, which is used for continual improvement of energy performance. Consumers spend an enormous amount of their budg …
- 世界のアウトドア服市場動向“Outdoor is a metaphor for freedom, adventure, adrenalin, extraversion, creativity, dynamism, and personal power.” Mike Lipkin, president of Lipkin/Environics Report extract: Outdoor brands have benefitted from the overall casualisation of apparel, while maintaining a “cool” factor based on an implied lifestyle of adventure, leisure, and sport. The pricing of high-end technical apparel makes these …
- Raynauds Disease：グローバル臨床試験レビューH2, 2013Raynauds Disease Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Raynauds Disease Global Clinical Trials Review, H2, 2013" provides data on the Raynauds Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Raynauds Disease. It includes an overview of the trial numbers and their recruitment statu …
- 2014年ヨーロッパの分子血液型・分類検査および感染症NAT（核酸増幅検査）市場Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five years, and assist industry executives in developing effective business, new produc …
- グローバル高温ガス炉（HTGR）/高温工学試験研究炉（HTTR）技術市場Global Overview of Opportunities and Key Developments in HTTR/HTGR Technology Summary Post-Fukushima, rising concern for human and environmental safety has seen countries invest in Generation IV (Gen IV) nuclear reactors such as High-Temperature Gas-Cooled Reactors and High-Temperature Test Reactors (HTGR/HTTR), which are safer and more efficient than traditional nuclear reactors. China is the lea …
- 世界の企業コンテンツ管理市場動向（2012-2016）TechNavio's analysts forecast the Global Enterprise Content Management market to grow at a CAGR of 12.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for regulatory compliance. The Global Enterprise Content Management market has also been witnessing an increased adoption of ECM in small and medium-sized enterprises (SMEs). However, existen …
- 車輪型トラクターの世界市場2014-2018About Wheeled Tractor A wheeled tractor is a heavy equipment, which helps in moving asphalt, dirt, snow, logs, raw materials, debris generation from demolition, rocks, sand, and raw materials during construction activities. It is used for carrying heavy materials as well as dump materials from construction and mining sites. These tractors are convertible into loaders based on the user's requiremen …
- Black Hills Corporation：石油・ガスバリューチェーン分析レポート2013Black Hills Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Black Hills Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Black Hills Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The re …
- 世界の前立腺酸性フォスファターゼ(PAP)検査 市場The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technolog …
- 有機ピープロテインの世界市場動向・予測（～2021）The global market for organic pea protein has grown exponentially in the last few years. In terms of value, the market is projected to reach USD 18.5 Million by 2021, at a CAGR of around 12.0% from 2016 to 2021. Factors such as increasing demand for organic products, rising vegan population, government support for organic farming, and high nutritional profile of peas drives the organic pea protein …
- 低密度ポリエチレン（LDPE）の世界市場The global LDPE market is estimated to grow at a CAGR of 3.8% from 2014 to 2019. The Asia-Pacific region holds the largest share of the global LDPE market as of 2014 and is expected to grow at the fastest CAGR of around 6% during the forecast period, 2014 to 2019. In this report, the LDPE market has been broadly classified on the basis of application and geography. The application segment is divid …
- 化学療法に伴う末梢神経障害：世界の臨床試験レビュー（2014年上半期）Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014" provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy …
- 坑井試験サービスの世界市場：ステージ（探査、評価、開発、生産）、用途別（オンショア、オフショア）、サービス別（リアルタイム抗井試験、ダウンホール抗井試験、油層サンプリング、地表抗井試験）、地域別予測Global Well Testing Services Market to reach USD 11.68 billion by 2025. Global Well Testing Services Market valued approximately USD 6.86 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6.09% over the forecast period 2017-2025. Due to rapidly increasing energy demand the exploration activities are increasing. New wells need to be drilled which contains enough oil and …
- 中国のテスト準備市場2016-2020About Test Preparation in China Benchmarking in education is immensely useful in measuring the performance of students, teachers, and schools and consequently evaluating and comparing education systems. The test preparation industry has emerged alongside the extensive standardization of the education sector in China. This standardization of the exams is prompting vendors to provide exam preparatio …
- ビッグデータの世界市場：ソフトウェア、サービス、構造化データ、半構造化データ、非構造化データThe big data market is estimated to grow from USD 28.65 Billion in 2016 to USD 66.79 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 18.45% during the forecast period. The analytics solutions have gained significant traction among various corporates due to the tremendously increasing data. Hence, the adoption of big data analytics solutions by various organizations across numerous indu …
